Masimo Corporation (MASI) CEO Joe Kiani on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/28/21
Masimo Introduces the MX-7™ rainbow SET® Technology Board for Original Equipment Manufacturing PartnersBusiness Wire • 07/19/21
Masimo to Report Second Quarter 2021 Financial Results after Market Close on Tuesday, July 27Business Wire • 07/13/21
New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU PatientsBusiness Wire • 07/06/21
Masimo Announces FDA 510(k) Clearance of Radius Tº™ for Prescription and Over-the-Counter (OTC) UseBusiness Wire • 06/21/21
New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung VentilationBusiness Wire • 06/14/21
Masimo (MASI) Down 4.6% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 05/26/21
New Study Assesses the Effects of Masimo Patient SafetyNet™ on Nursing Workflows in the General WardBusiness Wire • 05/17/21
Spacelabs Healthcare Partners with Masimo to Bring Advanced Measurements to Spacelabs Patient MonitorsBusiness Wire • 05/13/21
Study Investigates the Ability of Masimo O3® to Aid in Monitoring Septic Shock ICU Patients and Predicting MortalityBusiness Wire • 05/10/21
Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow TherapyBusiness Wire • 05/03/21
Masimo Corporation (MASI) CEO Joe Kiani on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/27/21